Title:
Ab8 COVID-19 Drug Breakthrough: Tiny Antibody Component Completely Neutralizes the SARS-CoV-2 Virus
By:
University of Pittsburgh
Published:
SciTechDaily, 14 September 2020
https://scitechdaily.com/ab8-covid-19-drug-breakthrough-tiny-antibody-component-completely-neutralizes-the-sars-cov-2-virus/
From the article:
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug — known as Ab8 — for potential use as a therapeutic and prophylactic against SARS-CoV-2.